Oct-07-16 Downgrade
JP Morgan
Overweight → Neutral
May-27-16 Initiated
Robert W. Baird
Neutral
$8
Dec-23-15 Reiterated
Mizuho
Buy
$16 → $13
Oct-27-15 Reiterated
Oppenheimer
Outperform
$13 → $15
Apr-21-15 Reiterated
Mizuho
Buy
$13 → $16
Oct-10-14 Resumed
Oppenheimer
Outperform
$9 → $11
Jul-08-14 Resumed
Brean Capital
Buy
$16
Jun-20-14 Reiterated
Oppenheimer
Outperform
$10 → $8.50
Aug-09-13 Reiterated
Oppenheimer
Outperform
$12 → $10
Jun-25-13 Initiated
Mizuho
Buy
$12
May-08-12 Initiated
Oppenheimer
Outperform
$12
Mar-10-21 06:00PM
Dec-10-20 02:10AM
Dec-03-20 07:46AM
Nov-29-20 12:12PM
Nov-05-20 08:20AM
Aug-07-20 08:20AM
Aug-05-20 08:33AM
May-07-20 06:10PM
Apr-02-20 08:30AM
Feb-07-20 11:14AM
Dec-22-19 07:44PM
Dec-03-19 09:15AM
08:45AM
Oct-28-19 06:04AM American City Business Journals
Sep-24-19 04:45PM
Sep-19-19 03:23PM
09:00AM
Aug-26-19 11:27AM American City Business Journals
09:00AM
Aug-22-19 08:30AM
Aug-16-19 09:15AM
Jul-25-19 08:30AM
May-31-19 07:34AM
06:21AM American City Business Journals
May-30-19 04:05PM
May-10-19 07:30AM
May-06-19 01:46PM
May-03-19 05:43PM
Apr-18-19 03:07PM
Apr-16-19 04:15PM
Apr-12-19 01:57PM
Apr-09-19 05:50PM
Apr-08-19 10:12AM
Apr-05-19 08:29AM
07:48AM
Apr-04-19 05:58PM American City Business Journals
04:15PM
Mar-07-19 09:06AM
Mar-06-19 07:00AM
Feb-12-19 07:35AM
Feb-11-19 09:39AM
Jan-28-19 10:19PM Thomson Reuters StreetEvents
Dec-10-18 05:00PM
Nov-09-18 10:31AM
08:45AM
Nov-08-18 10:17AM American City Business Journals
Nov-07-18 06:45AM
Nov-06-18 01:44PM
Nov-05-18 07:55AM
Oct-31-18 04:05PM
Oct-24-18 11:19AM
Oct-19-18 10:48AM
07:46AM
06:00AM
Oct-16-18 07:30AM
Oct-11-18 05:16PM
Sep-20-18 07:00AM
Sep-06-18 10:35AM
06:50AM
Sep-05-18 12:06PM Thomson Reuters StreetEvents
Sep-04-18 10:07AM
Aug-16-18 08:00AM
Aug-08-18 10:20AM
Aug-07-18 08:18AM
06:30AM
06:30AM
Aug-01-18 12:09PM
Jul-31-18 04:10PM
Jul-10-18 04:55PM
Jul-02-18 04:15PM
Jun-27-18 08:12AM
Jun-26-18 07:51PM
08:12AM
Jun-25-18 07:55AM
07:54AM
07:29AM
07:20AM
Jun-15-18 08:41AM
Jun-07-18 09:15AM
Jun-04-18 01:57PM Thomson Reuters StreetEvents
May-29-18 08:15AM
07:00AM
May-09-18 10:49AM
May-08-18 06:25AM
May-03-18 10:13AM
May-01-18 07:00AM
Apr-09-18 07:30AM
Apr-04-18 08:15AM
Mar-14-18 07:30AM
Mar-13-18 09:45AM
Mar-12-18 07:06PM Thomson Reuters StreetEvents
07:30AM
06:27AM
06:25AM
Mar-05-18 07:00AM
Feb-27-18 05:11AM
Feb-26-18 06:55AM
Feb-23-18 09:10AM
Feb-20-18 07:00AM
Feb-15-18 07:00AM
Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was founded in 1993 and is headquartered in Cambridge, Massachusetts.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Andersen Eric Director Apr 14 Buy 6.63 47,300 313,736 947,396 Apr 16 04:05 PM Andersen Eric Director Apr 13 Buy 6.26 9,874 61,780 906,591 Apr 15 04:05 PM Andersen Eric Director Apr 12 Buy 6.06 23,629 143,194 896,717 Apr 14 04:05 PM CROCKER GARY L See Remarks Apr 12 Buy 6.07 973 5,905 33,731 Apr 14 04:05 PM CROCKER GARY L See Remarks Apr 09 Buy 6.10 1,200 7,320 32,758 Apr 12 04:05 PM CROCKER GARY L See Remarks Apr 07 Buy 6.19 2,127 13,166 31,558 Apr 09 04:05 PM CROCKER GARY L See Remarks Mar 25 Buy 6.13 200 1,226 28,931 Mar 26 05:46 PM CROCKER GARY L See Remarks Mar 24 Buy 6.34 5,000 31,690 28,731 Mar 25 05:50 PM CROCKER GARY L See Remarks Mar 23 Buy 6.47 3,627 23,455 23,731 Mar 25 05:50 PM CROCKER GARY L See Remarks Mar 16 Buy 6.79 5,000 33,956 20,104 Mar 17 05:08 PM CROCKER GARY L See Remarks Feb 23 Buy 7.20 5,000 36,004 15,104 Mar 05 04:05 PM CROCKER GARY L See Remarks Feb 12 Buy 7.47 5,000 37,342 10,104 Feb 17 04:05 PM CROCKER GARY L See Remarks Feb 11 Buy 7.98 1,604 12,798 5,104 Feb 12 06:16 PM CROCKER GARY L See Remarks Feb 10 Buy 7.64 3,500 26,757 3,500 Feb 12 06:16 PM Levy Noah G. Director Dec 01 Buy 4.00 29,776 119,077 896,642 Dec 03 04:05 PM Andersen Eric Director Nov 24 Buy 3.65 69,088 252,171 873,088 Nov 27 04:05 PM Levy Noah G. Director Nov 24 Buy 3.65 69,087 252,168 879,283 Nov 27 04:05 PM Andersen Eric Director Nov 12 Buy 3.65 56,490 206,188 822,014 Nov 16 04:05 PM Levy Noah G. Director Nov 12 Buy 3.65 56,490 205,912 839,005 Nov 16 04:05 PM Levy Noah G. Director Aug 13 Buy 3.50 608 2,128 806,071 Aug 17 04:05 PM Andersen Eric Director Aug 13 Buy 3.50 609 2,132 820,055 Aug 17 04:05 PM Levy Noah G. Director Aug 12 Buy 3.49 2,000 6,986 805,717 Aug 13 04:05 PM Andersen Eric Director Aug 12 Buy 3.49 2,000 6,986 243,212 Aug 13 04:06 PM Andersen Eric Director Aug 11 Buy 3.45 14,030 48,437 241,212 Aug 13 04:06 PM Levy Noah G. Director Aug 11 Buy 3.45 14,042 48,480 804,551 Aug 13 04:05 PM Levy Noah G. Director Jul 22 Buy 3.11 177,274 552,087 796,365 Jul 24 06:59 PM Andersen Eric Director Jul 22 Buy 3.11 177,274 552,086 819,446 Jul 24 06:59 PM CROCKER GARY L See Remarks Jul 22 Sale 3.09 75,546 233,562 0 Jul 24 07:03 PM CROCKER GARY L See Remarks Jul 22 Sale 3.08 117,963 362,903 0 Jul 24 07:03 PM Levy Noah G. Director Apr 21 Buy 3.25 1,424 4,628 693,014 Apr 22 02:30 PM Andersen Eric Director Apr 21 Buy 3.25 1,424 4,628 692,768 Apr 22 02:27 PM Andersen Eric Director Apr 20 Buy 3.25 2,325 7,556 691,344 Apr 22 02:27 PM Levy Noah G. Director Apr 20 Buy 3.25 2,325 7,556 692,181 Apr 22 02:30 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite